Filing Details

Accession Number:
0001209191-18-058024
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-09 18:50:53
Reporting Period:
2018-11-08
Accepted Time:
2018-11-09 18:50:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
831547 Spectrum Pharmaceuticals Inc SPPI Pharmaceutical Preparations (2834) 930979187
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1273213 Iii E Anthony Maida 11500 S. Eastern Ave.
Suite 240
Henderson NV 89052
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2018-11-08 7,250 $3.92 40,238 No 4 M Direct
Common Stock, $0.001 Par Value Disposition 2018-11-08 7,250 $13.07 32,988 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Exercise (Right to Buy) Disposition 2018-11-08 7,250 $0.00 7,250 $3.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,050 2020-07-01 No 4 M Direct
Footnotes
  1. All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018.
  2. The stock option, representing the right to purchase a total of 30,000 shares of common stock, was granted on July 1, 2010. The stock option became exercisable as to 7,500 shares on July 1, 2010, 7,500 shares on July 1, 2011, 7,500 shares on July 1, 2012 and 7,500 shares on July 1, 2013.